Ian Morrison died yesterday. 5 years ago in one of the early THCB Gang’s, we had a rash of late cancellations. So I talked to Ian solo about his journey, and his views about health care. I re-listened to it this morning and thought you might enjoy it
By focusing on integrating care teams, expanding community programs, and addressing SDoH through policy reform, we can create a healthcare system that serves all patients — especially those most in need. The post Patients Across the Country Deserve Better Access to Healthcare appeared first on MedCity News.
This analysis compares 2021 data about deaths in the U.S. and 11 other large, wealthy countries by age and cause to understand the primary drivers of the longevity gap between the U.S. and the comparable countries. It finds that the primary reasons for the gap in 2021 were chronic disease, COVID-19 and substance use disorders.
By KIM BELLARD I am a fanboy for AI; I don’t really understand the technical aspects, but I sure am excited about its potential. I’m also a sucker for a catchy phrase. So when I (belatedly) learned about TinyAI, I was hooked. Now, as it turns out, TinyAI (also know as Tiny AI) has…
The organizations that will thrive in this environment are those that invest in resilience — the capacity to adapt, absorb strain, and maintain performance in the face of volatility. The post Success in Chaos: Building Resilient Systems for an Unpredictable Future appeared first on MedCity News.
Merative, a data, analytics and technology provider, is Morgan Health’s eighth portfolio company. The investment will help accelerate growth. The post Morgan Health Commits $25M to Merative to Enhance Employer Data Capabilities appeared first on MedCity News.
Astellas Pharma still looks to grow in cancer with a pipeline that includes internally developed programs that could stand out in oncology. But the drugmaker sees additional growth opportunities in ophthalmology and neuromuscular disorders, Chief Medical Officer Tadaaki Taniguci said. The post Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More…
Inozyme Pharma’s main asset is in pivotal testing in children who have a rare enzyme deficiency that affects bones and blood vessels. BioMarin Pharmaceutical, already well established in enzyme replacement, said it will use its experience and infrastructure to grow the market for this product, potentially for several indications. The post BioMarin’s $270M Inozyme Acquisition…
LOS ANGELES — For nearly a decade, John Baackes has led L.A. Care Health Plan, a publicly run insurer primarily serving low-income Los Angeles County residents on Medi-Cal. It is by far the largest Medi-Cal plan in the state. Baackes, 78, who will retire after the end of the year, helped transform L.A. Care into…
Vice President Kamala Harris is seeing a surge of support from Black women voters, galvanized in part by her work on health care issues such as maternal mortality, reproductive rights, and gun control. The enthusiasm may be key for Democratic turnout at the polls in critical battleground states. Black women have always been among the…